- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02491346
A Trial Comparing SGC and Conventional Empiric Treatment for Glucose Control in Critically Ill Patients With Mechanical Ventilation in ICU
A Randomized Controlled Trial Comparing SGC and Conventional Empiric Treatment for Glucose Control in Critically Ill Patients With Mechanical Ventilation in ICU
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Design: The study was conducted as a single-centre, open randomized controlled, parallel trial.
Study population: Adult medical ICU patients who were mechanically ventilated and assumed to require at least 3 days of intensive care were recruited. Patients fulfilling the inclusion criterion of glucose≥9.0 mM were randomly assigned using serially numbered to either the intervention group (BG control by SGC) or the control group (conventional empiric BG management). The both group aim to establish the BG levels 5.8-8.9mM.
Study protocol: BG measurements were performed using glucometer to test the fingertip capillary blood sample for the BG levels. As for patients with shock or required vasopressor, arterial BG was sampled to measure through the glucometer. Insulin [40 IU of Actrapid HM (Wanbang Biopharmaceuticals, Jiangsu province, China)/40ml of 0.9% sodium chloride] was infused intravenously applying the standard perfusor of the ICU (Perfusor®Space, B. Braun Melsungen AG, Melsungen, Germany). All trial-related activities were carried out until the end of the patient's ICU stay, or for a period of 72 hours. Meanwhile, enteral and parenteral nutrition was administrated to patients according to their condition.
Statistical analysis was performed on an intention-to-treat basis. The percentage of values in the target range (5.8-8.9mM) was defined as primary end point for the assessment of glucose control. Data are reported as mean±SD values if not otherwise indicated. Data analysis was performed using SPSS19.0.
Study Type
Enrollment (Anticipated)
Phase
- Phase 4
Contacts and Locations
Study Contact
- Name: Bin Du, Dr.
- Phone Number: 86-010-69155046
- Email: dubin98@gmail.com
Study Locations
-
-
Beijing
-
Beijing, Beijing, China, 100730
- Recruiting
- MICU of Peking Union Medical College Hospital
-
Contact:
- Bin Du, Dr
- Phone Number: 86-010-69155046
- Email: dubin98@gmail.com
-
Principal Investigator:
- Bin Du, Doctor
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Admitted to the ICU
- At least one BG measurement 9.0mmol/L or higher
- Expected to stay in ICU ≥3 days;
- Mechanical ventilation
Exclusion Criteria:
- Aged < 18 years;
- Admitted because of diabetic ketoacidosis or nonketotic hyperosmolar state
- Pregnant
- In a state in which death was perceived as imminent
- Without written informed consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: conventional empirical glycemic control
the patients' blood glucose is controlled by physician according to their experience through insulin subcutaneous injection or insulin continuous infusion whose dosage is determinated by the physician.
|
the patients' blood glucose is controlled by physician according to their experience through insulin subcutaneous injection or insulin continuous infusion whose dosage is determinated by the physician.
Other Names:
|
Experimental: SGC directed glycemic control
the patients' blood glucose is controlled by SGC system through insulin continuous infusion whose dosage is determinated by SGC.
|
the patients' blood glucose is controlled by SGC system through insulin continuous infusion whose dosage is determinated by SGC.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
the percentage of time within the predefined glucose the target range(5.8-8.9mmol /l)
Time Frame: 6 months
|
6 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Bin Du, Dr, MICU of Peking Union Medical College Hospital
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MICU_2014-11
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hyperglycemia
-
Mayo ClinicCompletedHospital Hyperglycemia | Post-transplant HyperglycemiaUnited States
-
Zealand University HospitalNot yet recruitingStress Hyperglycemia | Postoperative Hyperglycemia
-
University of CopenhagenUnknownSurgery--Complications | Hyperglycemia Stress | Hyperglycemia Steroid-inducedDenmark
-
University of LeedsCompletedEffect of Food on Postprandial HyperglycemiaUnited Kingdom
-
Emory UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...RecruitingHyperglycemia StressUnited States
-
Loughborough UniversityUniversity of BedfordshireCompletedPostprandial HyperglycemiaUnited Kingdom
-
Centre Hospitalier Universitaire de BesanconEli Lilly and Company; AstraZenecaCompleted
-
Medical University of ViennaCompleted
-
Addis Ababa UniversityCompletedHyperglycemia, Postprandial
-
University of Eastern FinlandFinnsugar LtdCompletedHyperglycemia, PostprandialFinland
Clinical Trials on conventional empirical glycemic control
-
The University of Texas Health Science Center,...National Institutes of Health (NIH)Terminated
-
Poissy-Saint Germain HospitalUnknownHyperglycemia | Critically Ill PatientsFrance
-
University of Medicine and Dentistry of New JerseyTerminatedHyperglycemiaUnited States
-
James A. Haley Veterans Administration HospitalUniversity of South FloridaCompletedHyperglycemia | Diabetes | Surgical Site InfectionUnited States
-
Ramon OliveiraTerminatedLiver Transplantation | Surgical Wound InfectionBrazil
-
Temple UniversityMedical University of South Carolina; National Institute of Neurological Disorders... and other collaboratorsCompletedHyperglycemia | Stroke | Procoagulation MarkersUnited States
-
Hospital de Clinicas de Porto AlegreCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.; Conselho Nacional...CompletedObesity | Female InfertilityBrazil
-
University of California, DavisCompleted
-
Hospital de Clinicas de Porto AlegreUnknownKidney Failure, Chronic | End-Stage Renal DiseaseBrazil